These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The vasoprostan treatment of patients with Raynaud's syndrome]. Alekperov RT; Mach ES; Guseva NG Ter Arkh; 1997; 69(8):22-3. PubMed ID: 9381386 [No Abstract] [Full Text] [Related]
4. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Gore J; Silver R Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356 [No Abstract] [Full Text] [Related]
17. [Recent advances in Raynaud's syndrome]. Klein-Weigel P Dtsch Med Wochenschr; 2012 Mar; 137(13):622-4. PubMed ID: 22434167 [No Abstract] [Full Text] [Related]
18. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment. Kumar N; Griffiths B; Allen J J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964 [No Abstract] [Full Text] [Related]
19. Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al. Lichtenstein JR Arthritis Rheum; 2003 Jan; 48(1):282-3; author reply 283. PubMed ID: 12528146 [No Abstract] [Full Text] [Related]
20. [How I treat...Raynaud's phenomenon]. Piérard GE Rev Med Liege; 1998 Mar; 53(3):119-20. PubMed ID: 9594609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]